Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
07/05/2019 - 3 minutes
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
Confo Therapeutics has joined forces with Roche to develop new small molecule agonists of a…
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein…
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…
Confo Therapeutics has received a €1.6M grant to support the discovery of drugs against fibrosis,…